Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment

Clinical trial NCT04667299 · UNKNOWN

Trial details

NCT number: NCT04667299
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Helicobacter Pylori Infection

Start date: 2020-12-20
Primary completion: 2021-11-20
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.